Related Experiment Video

Updated: May 31, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

[Melanoma: a new therapeutic era]

G Berthod1, K Homicsko, H Bouchaab

  • 1Centre pluridisciplinaire d'oncologie, CHUV, Lausanne. gregoire.berthod@chuv.ch

Revue Medicale Suisse
|July 5, 2011
PubMed

Insights

Melanoma incidence is rapidly increasing, particularly in younger adults. This review covers new targeted therapies and immunotherapies like tyrosine kinase inhibitors (TKI) and CTLA-4 blockade for advanced melanoma.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Context:

  • Melanoma exhibits the fastest rising incidence in Switzerland.
  • A significant portion (30%) of melanoma cases occur before age 50.
  • Metastatic melanoma has a poor prognosis with current therapies, showing a median survival of approximately 8 months.

Purpose:

  • To review recent advancements in melanoma treatment.
  • To discuss the efficacy of novel therapeutic strategies.
  • To highlight progress in understanding melanoma biology and immunity.

Summary:

  • This review examines targeted therapies, specifically tyrosine kinase inhibitors (TKI).
  • It also covers immunotherapies, including monoclonal antibodies targeting the CTLA-4 receptor on lymphocytes.
  • These therapies represent promising new avenues for managing advanced melanoma.

Impact:

  • Novel therapies offer improved outcomes for melanoma patients.
  • Advancements in understanding cellular biology and immunity are driving treatment innovation.
  • This review provides insights into the latest developments in melanoma management.

More Related Videos

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models05:33

Unveiling Therapeutic Opportunities with Melanoma Patient-derived Organoid Models

Published on: September 6, 2024

A Melanoma Patient-Derived Xenograft Model07:07

A Melanoma Patient-Derived Xenograft Model

Published on: May 20, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...